Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 8;13(6):1027.
doi: 10.3390/genes13061027.

Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome

Affiliations

Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome

Yanireth Jimenez et al. Genes (Basel). .

Abstract

Marfan Syndrome (MFS) is an autosomal dominant condition caused by variants in the fibrillin-1 (FBN1) gene. Cardinal features of MFS include ectopia lentis (EL), musculoskeletal features and aortic root aneurysm and dissection. Although dissection of the ascending aorta is the main cause of mortality in MFS, the clinical course differs considerably in age of onset and severity, even among individuals who share the same causative variant, suggesting the existence of additional genetic variants that modify the severity of the cardiovascular phenotype in MFS. We recruited MFS patients and classified them into severe (n = 8) or mild aortic phenotype (n = 14) according to age of presentation of the first aorta-related incident. We used Exome Sequencing to identify the genetic variants associated with the severity of aortic manifestations and we performed linkage analysis where suitable. We found five genes associated with severe aortic phenotype and three genes that could be protective for this phenotype in MFS. These genes regulate components of the extracellular matrix, TGFβ pathway and other signaling pathways that are involved in the maintenance of the ECM or angiogenesis. Further studies will be required to understand the functional effect of these variants and explore novel, personalized risk management and, potentially, therapies for these patients.

Keywords: Marfan syndrome; aortic aneurysm; exome sequencing; genetic modifiers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Familial and sporadic cases of MFS with significant variation in severity of their aortic phenotype. MFS clinical diagnosis was confirmed through identification of pathogenic variants in FBN1 (see Table 1). Stratification of patients was done as described in Supplementary Table S1).

References

    1. Robinson P.N., Arteaga-Solis E., Baldock C., Collod-Béroud G., Booms P., De Paepe A., Dietz H.C., Guo G., Handford P.A., Judge D.P., et al. The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet. 2006;43:769–787. doi: 10.1136/jmg.2005.039669. - DOI - PMC - PubMed
    1. Keane M.G., Pyeritz R.E. Medical management of marfan syndrome. Circulation. 2008;117:2802–2813. doi: 10.1161/CIRCULATIONAHA.107.693523. - DOI - PubMed
    1. Sakai L.Y., Keene D.R., Renard M., De Backer J. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene. 2016;592:279–291. doi: 10.1016/j.gene.2016.07.033. - DOI - PMC - PubMed
    1. Dietz H.C., Cutting C.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., Puffenberger E.G., Hamosh A., Nanthakumar E.J., Curristin S.M., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–339. doi: 10.1038/352337a0. - DOI - PubMed
    1. Li Y., Xu J., Chen M., Du B., Li Q., Xing Q., Zhang Y. A FBN1 mutation association with different phenotypes of Marfan syndrome in a Chinese family. Clin. Chim. Acta. 2016;460:102–106. doi: 10.1016/j.cca.2016.06.031. - DOI - PubMed

Publication types